Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane + Cisplatin vs Gemcitabine + Cisplatin in Advanced NSCLC
NCT01810367Phase 2Completed
- Sponsor
- Fudan University
- Start
- Dec 2011
- Primary completion
- Dec 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Fudan University. Started Dec 2011; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01810367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810367.